Literature DB >> 15107622

Control of tumor suppressor p53 function by endoplasmic reticulum stress.

Like Qu1, Antonis E Koromilas.   

Abstract

Alterations in the homeostasis of the endoplasmic reticulum (ER) by various forms of stress can lead to the accumulation of unfolded proteins and protein aggregates that are detrimental to cell survival. Eukaryotic cells can adapt to ER stress by activating specific signaling pathways and mechanisms, whose primary purpose is to limit the accumulation of unfolded proteins in the ER. We recently reported a novel mechanism of cell adaptation to ER stress, which proceeds through the inhibition of the apoptotic function of the tumor suppressor p53 (Genes Dev 2004;18:261-277). We found that ER stress increases the cytoplasmic localization and enhances the destabilization of the tumor suppressor. This process requires the phosphorylation of p53 at serine 315 and serine 376, which is mediated by the activation of glycogen synthase kinase-3beta (GSK-3beta). ER stress also prevents p53 activation and p53-mediated apoptosis in response to DNA damage. These findings demonstrate that ER stress utilizes mechanisms that are distinct from other types of stress to modulate p53. In addition, they reveal that ER stress and nuclear DNA damage can induce inter-organellar cross-talk pathways targeting p53 with important implications for the treatment of tumors with dysfunctional ER.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107622

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  6 in total

1.  What's new in p53?

Authors:  D Maritsi; D Stagikas; K Charalabopoulos; A Batistatou
Journal:  Hippokratia       Date:  2006-07       Impact factor: 0.471

2.  PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress.

Authors:  Philip Nickson; Ambrus Toth; Peter Erhardt
Journal:  Cardiovasc Res       Date:  2006-10-06       Impact factor: 10.787

3.  Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.

Authors:  Qingjun Liu; James W Mier; David J Panka
Journal:  Mol Cancer       Date:  2011-09-19       Impact factor: 27.401

4.  Evidence for eIF2α phosphorylation-independent effects of GSK2656157, a novel catalytic inhibitor of PERK with clinical implications.

Authors:  Jothilatha Krishnamoorthy; Kamindla Rajesh; Farzaneh Mirzajani; Polixenia Kesoglidou; Andreas I Papadakis; Antonis E Koromilas
Journal:  Cell Cycle       Date:  2014-01-08       Impact factor: 4.534

5.  Proteomic analyses of brain tumor cell lines amidst the unfolded protein response.

Authors:  Jasmina S Redzic; Joe D Gomez; Justin E Hellwinkel; Thomas J Anchordoquy; Michael W Graner
Journal:  Oncotarget       Date:  2016-07-26

6.  RITA requires eIF2α-dependent modulation of mRNA translation for its anti-cancer activity.

Authors:  Johannes Ristau; Vincent van Hoef; Sylvain Peuget; Jiawei Zhu; Bo-Jhih Guan; Shuo Liang; Maria Hatzoglou; Ivan Topisirovic; Galina Selivanova; Ola Larsson
Journal:  Cell Death Dis       Date:  2019-11-07       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.